back to Australia directory
australia clinical guidance

Iron deficiency anaemia (adults)

A detailed Australian summary of iron deficiency anaemia (adults), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Confirm iron deficiency with ferritin interpreted alongside inflammation and assess haemoglobin severity, indices, reticulocytes and previous trend. Seek a cause through menstrual, gastrointestinal, dietary, blood donation, pregnancy, malabsorption and medicine history rather than treating indefinitely without explanation. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:NBA PBM Module 3

The Bottom Line

  • Confirm iron deficiency with ferritin interpreted alongside inflammation and assess haemoglobin severity, indices, reticulocytes and previous trend.
  • Seek a cause through menstrual, gastrointestinal, dietary, blood donation, pregnancy, malabsorption and medicine history rather than treating indefinitely without explanation.
  • Take oral iron away from inhibitors when tolerated, but prioritize a regimen the person can adhere to over maximal theoretical absorption.
  • Adults without an obvious benign explanation may need coeliac testing and age- and risk-appropriate gastrointestinal investigation for occult bleeding or cancer.
sources for this section:NBA PBM Module 3

Practical clinical workflow

1

Topic-specific assessment action

Confirm iron deficiency with ferritin interpreted alongside inflammation and assess haemoglobin severity, indices, reticulocytes and previous trend.
2

Topic-specific diagnostic action

Adults without an obvious benign explanation may need coeliac testing and age- and risk-appropriate gastrointestinal investigation for occult bleeding or cancer.
3

Topic-specific management action

Choose oral or intravenous iron by severity, tolerance, absorption, ongoing loss and urgency, and document response with haemoglobin and iron stores.
4

Topic-specific follow-through

Failure to rise should trigger review of adherence, ongoing bleeding, inflammation, malabsorption and whether the original diagnosis was correct.
sources for this section:NBA PBM Module 3

Safety boundaries and escalation

  • Haemodynamic instability, chest pain, syncope, active bleeding, severe breathlessness or failure to respond as expected requires urgent escalation or haematology advice.
  • In heart failure or inflammatory bowel disease, intravenous iron decisions use disease-specific criteria rather than ferritin alone.
sources for this section:NBA PBM Module 3

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:NBA PBM Module 3

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:NBA PBM Module 3

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. National Blood Authority AustraliaPatient Blood Management Guidelines: Module 3 — MedicalMedical module; exact NBA-hosted edition checked 2026-08-20 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.